
Yale Researcher's 25-Year Quest Delivers New Cancer Drug
A groundbreaking breast cancer therapy just became the first FDA-approved drug of its kind, born from Yale research that began over two decades ago. The new treatment offers hope to thousands of women with an aggressive form of breast cancer.

















